PlainRecalls
FDA Devices Moderate Class II Ongoing

BD Ultra-Fine Insulin Syringe 0.5mL, 6mm, 31G - Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326679

Reported: March 22, 2023 Initiated: February 1, 2023 #Z-1237-2023

Product Description

BD Ultra-Fine Insulin Syringe 0.5mL, 6mm, 31G - Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326679

Reason for Recall

Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

Details

Units Affected
45, 000 units
Distribution
Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.
Location
Franklin Lakes, NJ

Frequently Asked Questions

What product was recalled?
BD Ultra-Fine Insulin Syringe 0.5mL, 6mm, 31G - Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326679. Recalled by Becton Dickinson & Company. Units affected: 45, 000 units.
Why was this product recalled?
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.
Which agency issued this recall?
This recall was issued by the FDA Devices on March 22, 2023. Severity: Moderate. Recall number: Z-1237-2023.